mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.15 |
0.02 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.02 |